In clinical application, protein molecules such as cytokeratin 19 fragment (CYFRA21-1), carcino-embryonic antigen (CEA) and neuron-specific enolase (NSE) are commonly used for the diagnosis of lung cancer. This evidence concerns the gene ENO2 and lung cancer.